Mallinckrodt Plc
(NYSE : MNK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
4.92%15.151.8%$165.06m
VRXValeant Pharmaceuticals International, Inc.
2.01%21.3014.1%$125.33m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.83%154.196.2%$81.03m
PRGOPerrigo Co. Plc
1.05%46.156.8%$70.07m
SAGESAGE Therapeutics, Inc.
0.60%162.008.6%$61.94m
JAZZJazz Pharmaceuticals Plc
2.62%134.832.3%$54.72m
HZNPHorizon Pharma plc
0.60%27.006.7%$46.88m
UTHRUnited Therapeutics Corporation
2.33%81.3714.3%$44.61m
PTLAPortola Pharmaceuticals, Inc.
-0.36%30.417.5%$42.98m
ICLRICON Plc
1.32%157.174.1%$40.19m
ICPTIntercept Pharmaceuticals, Inc.
-0.99%64.0017.2%$38.64m
CTLTCatalent Inc
1.10%55.882.4%$35.42m
MDCOMedicines Company
3.78%32.7120.3%$33.51m
AERIAerie Pharmaceuticals, Inc.
-5.62%23.196.8%$25.01m
PCRXPacira Pharmaceuticals, Inc.
-1.85%38.2210.5%$24.00m

Company Profile

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.